MyFinsight
Home
Blog
About
Back
Income Statement
ENANTA PHARMACEUTICALS INC (ENTA)
ENANTA PHARMACEUTICALS INC (ENTA)
source: myfinsight.com
Net loss
-$19,501K
(-6.83%↓ Y/Y)
Loss before income
taxes
-$19,465K
(-6.80%↓ Y/Y)
Income tax (expense)
benefit
$36K
(24.14%↑ Y/Y)
Loss from operations
-$17,236K
(8.77%↑ Y/Y)
Total other (expense)
income, net
-$2,229K
(-434.18%↓ Y/Y)
Total revenue
$14,359K
(-21.60%↓ Y/Y)
Interest and investment
income, net
$1,901K
(-16.81%↓ Y/Y)
Total operating
expenses
$31,595K
(-15.08%↓ Y/Y)
Interest expense
$4,130K
(155.25%↑ Y/Y)
Research and development
$22,126K
(-18.68%↓ Y/Y)
General and
administrative
$9,469K
(-5.28%↓ Y/Y)
Back